PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Gastroenterology Department, Hospital Universitari Germans Trias i Pujol, Carretera del Canyet s/n, 08916, Badalona, Catalonia, Spain.\', \'Centro de Investigación Biomédica en red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Catalonia, Spain.\', \'Pharmacy Department, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain.\', \'Gastroenterology Department, Hospital Universitari Germans Trias i Pujol, Carretera del Canyet s/n, 08916, Badalona, Catalonia, Spain. eugenidomenech@gmail.com.\', \'Centro de Investigación Biomédica en red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Catalonia, Spain. eugenidomenech@gmail.com.\', \'Departament de Medicina, Universitat Autònoma de Barcelona, Catalonia, Spain. eugenidomenech@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s10620-020-06807-0
?:doi
?:hasPublicationType
?:journal
  • Digestive diseases and sciences
is ?:pmid of
?:pmid
?:pmid
  • 33469807
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.33
?:rankingScore_hIndex
  • 110
?:title
  • Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all